These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 7908306
1. Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade. Chavin KD, Qin L, Yon R, Lin J, Yagita H, Bromberg JS. J Immunol; 1994 Apr 15; 152(8):3729-39. PubMed ID: 7908306 [Abstract] [Full Text] [Related]
2. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes. Cassell D, Forman J. J Immunol; 1991 Jan 01; 146(1):3-10. PubMed ID: 1670605 [Abstract] [Full Text] [Related]
3. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction. Hirsch R, Archibald J, Gress RE. J Immunol; 1991 Oct 01; 147(7):2088-93. PubMed ID: 1833451 [Abstract] [Full Text] [Related]
4. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2. Lin J, Yon RW, Chavin KD, Qin L, Woodward J, Ding Y, Yagita H, Bromberg JS. Transplantation; 1995 Apr 27; 59(8):1162-71. PubMed ID: 7537394 [Abstract] [Full Text] [Related]
8. Suppressor T cells induced by epidermally applied hapten are located in bone marrow. Kuo TS, Matriano J, Ferguson TA, Battisto JR. Reg Immunol; 1989 Apr 27; 2(6):399-407. PubMed ID: 2534991 [Abstract] [Full Text] [Related]
10. Role of CD2 in activation and cytotoxic function of CD8/Leu-7-positive T cells. Rüthlein J, James SP, Strober W. J Immunol; 1988 Dec 01; 141(11):3791-7. PubMed ID: 2903195 [Abstract] [Full Text] [Related]
12. IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes. Good MF, Powell LW, Halliday JW. Immunology; 1989 Jun 01; 67(2):225-30. PubMed ID: 2568977 [Abstract] [Full Text] [Related]
13. The effects of anti-CD2 antibodies on the differentiation of mouse thymocytes. Kyewski BA, Jenkinson EJ, Kingston R, Altevogt P, Owen MJ, Owen JJ. Eur J Immunol; 1989 May 01; 19(5):951-4. PubMed ID: 2567676 [Abstract] [Full Text] [Related]
14. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes. Baadsgaard O, Fox DA, Cooper KD. J Immunol; 1988 Mar 15; 140(6):1738-44. PubMed ID: 2964481 [Abstract] [Full Text] [Related]
16. Antibody 12-15 cross-reacts with mouse Fc gamma receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 protein. Altevogt P, Kohl U, Von Hoegen P, Lang E, Schirrmacher V. Eur J Immunol; 1989 Feb 15; 19(2):341-6. PubMed ID: 2564824 [Abstract] [Full Text] [Related]
17. Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. Bromberg JS, Chavin KD, Altevogt P, Kyewski BA, Guckel B, Naji A, Barker CF. Transplantation; 1991 Jan 15; 51(1):219-25. PubMed ID: 1670971 [Abstract] [Full Text] [Related]
19. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway. Pereira GM, Miller JF, Shevach EM. J Immunol; 1990 Mar 15; 144(6):2109-16. PubMed ID: 1968924 [Abstract] [Full Text] [Related]
20. Persistent suppression of virus-specific cytotoxic T cell responses after transient depletion of CD4+ T cells in vivo. Goronzy JJ, Weyand CM. J Immunol; 1989 Jun 15; 142(12):4435-40. PubMed ID: 2524530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]